Study design and population
Each study was a multicenter open-label non-controlled study in Japanese pediatric outpatients that occurred during the 2016–17 [Patients were enrolled in the baloxavir tablet study if they were ≥ 1 to < 12 years, were capable of swallowing a tablet, and had a body weight ≥ 5 kg and a body mass index < 40 kg/m